Effect of Treatment with the PD-1/PD-L1 Inhibitors on Key Health Outcomes of Cancer Patients

ConclusionsAnti-PD ‐1/PD‐L1 therapy is expected to provide marked survival benefits for patients with cancer. This study demonstrated the potentially beneficial health impacts of utilizing the anti-PD‐1/PD‐L1 class at the population level. The findings could inform health policy decision makers about cancer ca re and ultimately enhance population health through rapid access to innovative cancer drugs.
Source: BioDrugs - Category: Drugs & Pharmacology Source Type: research